Categories: world

Two Oklahoma hospitals were fought by deadly sponge “superbug” | State and regional

It was not published locally but in recent years, teams of health officers at two Oklahoma health care facilities took rapid action to contain the spread of a "superbug" fungus which federal officials have declared a serious global health risk. 19659002] Only one patient at each plant was infected and both patients recovered. However, the incidents reflect the growing alarm of health care professionals over the lethal, multi-drug resistant Candida auris or C. auris, which can kill 30% to 60% of those infected. Oklahoma is one of 1 2 states that had reported confirmed cases of fungus since February. By comparison, Texas reported one and two California. The problem is much more serious in New York, with 309 confirmed cases and Illinois, with 144. In April 2017, a team of experts from the Federal Centers for Disease Control and Prevention at the University of Oklahoma Medical Center in Oklahoma City converged for a patient which tested positive for the drug resistant fungus. About a year later, a patient at a southeast Oklahoma health facility tested positive for the bacterium during a routine test. In both cases, health care patients isolated, locked their rooms and ordered dozens of laboratory tests to see if the fungus had spread. Unlike outbreaks in Illinois, New York and New Jersey, the potentially fatal infection was rapid. But the two cases highlight the risks associated with C. auris, a bacterium that worried the CDC enough to issue a clinical warning in 2016 for all US medical…

It was not published locally but in recent years, teams of health officers at two Oklahoma health care facilities took rapid action to contain the spread of a “superbug” fungus which federal officials have declared a serious global health risk. 19659002] Only one patient at each plant was infected and both patients recovered. However, the incidents reflect the growing alarm of health care professionals over the lethal, multi-drug resistant Candida auris or C. auris, which can kill 30% to 60% of those infected.

Oklahoma is one of 1

2 states that had reported confirmed cases of fungus since February. By comparison, Texas reported one and two California. The problem is much more serious in New York, with 309 confirmed cases and Illinois, with 144.

In April 2017, a team of experts from the Federal Centers for Disease Control and Prevention at the University of Oklahoma Medical Center in Oklahoma City converged for a patient which tested positive for the drug resistant fungus.

About a year later, a patient at a southeast Oklahoma health facility tested positive for the bacterium during a routine test. In both cases, health care patients isolated, locked their rooms and ordered dozens of laboratory tests to see if the fungus had spread.

Unlike outbreaks in Illinois, New York and New Jersey, the potentially fatal infection was rapid.

But the two cases highlight the risks associated with C. auris, a bacterium that worried the CDC enough to issue a clinical warning in 2016 for all US medical centers to look for suspected cases. State and local health officials say the rise in Oklahoma is a reminder that hospitals, health clinics, and even nursing homes must be aware of the new threat.

“It’s hard to speculate on what we may or may not see in the future,” says Interim State Epidemiologist Laurence Burnsed. “But the important thing is to be aware of the challenges that are trying to limit transmission and risk.”

An Emerging hot

First discovered in Japan in 2009, C. auris has spread in more than 30 countries, including the United Kingdom,

In an update from 2017 to its clinical warning, CDC reported health facilities that a number of patients tested positive with the mushroom in the hospital after traveling abroad, including India, Pakistan, South Africa and Venezuela.

But the agency also noted that those who have not traveled abroad also risk that the yeast can spread from person to person, colonize the patient’s skin and survive on door handles, tray table and other surfaces for several months

The fungus can then enter the bloodstream and cause potentially fatal infections. one shows that sometimes half of those who kill it, even if they are usually weak or have compromised the immune system. Elderly patients at long-term nursing homes, especially those with catheters, are at increased risk.

The CDC warns that many disinfectants commonly used in the healthcare industry are ineffective in stopping the fungus. Some strains are resistant to all three major classes of fungicides.

Contains the threat

Due to privacy concerns, the Oklahoma State Department of Health would not disclose where the state’s two reported cases occurred, except to say that one occurred in Oklahoma County and the other in southeastern Oklahoma.

“I hesitate to go into some details because over time and the site could lead to the identification of the patients,” Burnsed said.

However, published documents, including a PowerPoint presentation and the article on the CDC website, suggest that the April 2017 case occurred at the OU Medical Center. The hospital confirmed the case in a statement to Oklahoma Watch.

The documents paint the seriousness of the situation by describing how a three-person team from the CDC, including an expert on fungal infections, helped state and local health care professionals to take 73 samples, including tray tables and door handles, and send them to CDC labs over a two-day period.

Hospital managers also examined samples taken over a period of about a year to exclude the possibility that the patient caught the bacterium in the hospital.

The digital presentation from the hospital’s infection control officer notes that the hospital’s officials did not find anything outside the patient’s room and believe that it came from the hospital.

OU Medicine Chief Quality Officer Dr. Dale Bratzler said the patient acquired the infection in Asia and was already isolated because of several infections from drug-resistant organisms when C. auris was identified.

“The most importan Part of our OU Medicine strategy for this type of infection is early detection,” he says. “Our laboratory can quickly identify this organism if we ever see another patient with it.”

During the April event, the CDC also worked with hospital staff to review its infection control strategy and review how to conduct environmental sampling so that future tests can be done on site. “” The work in Oklahoma was considered successful because the CDC did not find additional evidence of transfer, “the CDC said. epidemiologist Karlyn Beer in the CDC article “This is a testament to the quality of the hospital’s laboratory monitoring, infection control and its commitment to finding and preventing C. auris transmission.”

When to reveal

Public Knowledge of the OU Case Medical Center makes it an exception, typically healthcare facilities across the nation do not escape public information are C. auris and other drug resistant pathogens are present. No law or policy requires them to do so.

Patient rights advocates claim that the public has the right to know when and where outbreaks or even individual cases arise. However, health officials have routinely struggled back, suggesting that it can break the patient’s rights and discourage patients from seeking medical care.

The CDC allows states to make the decision.

Burnsed said the Department of Health is trying to go a tight line between notifying the public and protecting the privacy of the patient.

He said he would be more likely to identify a facility if it was more than an isolated case or if officials believed that the exposure was not. [19659002] “What we believe is there was a risk for a wider group of individuals and if there was any evidence that there was a breach of laboratory control,” Burnsed said. “We didn’t knock anything out (in Oklahoma’s two case) because we did not think there was a greater risk to the public, but it is a good question to consider. “

Share
Published by
Faela